Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

Cindy L. Grines, Kevin F. Browne, Jean Marco et al. · New England Journal of Medicine · 1993 · 2K citations · Full text

The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction

The GUSTO Angiographic Investigators · New England Journal of Medicine · 1993 · 1.9K citations · Full text

In-Stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia

Ran Kornowski, Mun K. Hong, Fermin O. Tio et al. · Journal of the American College of Cardiology · 1998 · 842 citations

Inflammation, Inflammatory Responses, Vascular Disease +11

THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

M. L. Simoons · The Lancet · 1988 · 660 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9